Survival outcomes with matched targeted therapy in advanced biliary tract cancer: a large global cohort analysis

Abstract The prognosis of advanced biliary tract cancer remains poor despite up to 40% of tumors harboring actionable molecular alterations. This international collaborative study from Mayo Clinic, Duke Cancer Institute, National Cancer Center East (Japan), and the SCRUM-Japan GOZILA/MONSTAR-SCREEN...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Binbin Zheng-Lin, Taro Shibuki, Heidi E. Kosiorek, Oluseyi Abidoye, Cody R. Eslinger, Yasuyuki Kawamoto, Ryne C. Ramaker, Shinji Itoh, Tadayoshi Hashimoto, Takao Fujisawa, Mitsuho Imai, Angelo Pirozzi, Celine Hoyek, Mohamad B. Sonbol, Christina Wu, Nguyen H. Tran, Hani Babiker, Lewis R. Roberts, Ashley N. Moyer, Yoshiaki Nakamura, Hideaki Bando, Takayuki Yoshino, Makoto Ueno, Chigusa Morizane, Daniel H. Ahn, Madhuri Gottam, Mitesh J. Borad, John H. Strickler, Masafumi Ikeda, Tanios Bekaii-Saab
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Nature Portfolio 2026-05-01
Saila:	npj Precision Oncology
Sarrera elektronikoa:	https://doi.org/10.1038/s41698-026-01457-3
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!